These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1361372)

  • 1. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
    Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
    Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation.
    Inghirami G; Macri L; Cesarman E; Chadburn A; Zhong J; Knowles DM
    Blood; 1994 Jun; 83(12):3581-90. PubMed ID: 8204884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y; Koeffler HP
    Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction.
    Chadburn A; Athan E; Wieczorek R; Knowles DM
    Blood; 1991 Jun; 77(11):2419-30. PubMed ID: 2039822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.
    Yamato K; Oka T; Hiroi M; Iwahara Y; Sugito S; Tsuchida N; Miyoshi I
    Jpn J Cancer Res; 1993 Jan; 84(1):4-8. PubMed ID: 8449826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24.
    Lanza C; Gaidano G; Cimino G; Lo Coco F; Basso G; Sainati L; Pastore C; Nomdedeu J; Volpe G; Parvis G
    Leukemia; 1995 Jun; 9(6):955-9. PubMed ID: 7596184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma).
    Matolcsy A; Inghirami G; Knowles DM
    Blood; 1994 Mar; 83(5):1363-72. PubMed ID: 8118038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
    Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
    Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
    Waber PG; Chen J; Nisen PD
    Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alteration of p53 in some patients with adult T-cell leukemia.
    Nagai H; Kinoshita T; Imamura J; Murakami Y; Hayashi K; Mukai K; Ikeda S; Tobinai K; Saito H; Shimoyama M
    Jpn J Cancer Res; 1991 Dec; 82(12):1421-7. PubMed ID: 1778765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.
    Sugimoto KJ; Kawamata N; Sakajiri S; Oshimi K
    Jpn J Cancer Res; 2002 Nov; 93(11):1270-7. PubMed ID: 12460470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of cutaneous B- and T-cell lymphomas.
    Neri A; Fracchiolla NS; Roscetti E; Garatti S; Trecca D; Boletini A; Perletti L; Baldini L; Maiolo AT; Berti E
    Blood; 1995 Oct; 86(8):3160-72. PubMed ID: 7579411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes and tumor-suppressor genes.
    Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC
    Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.
    Cesarman E; Inghirami G; Chadburn A; Knowles DM
    Am J Pathol; 1993 Sep; 143(3):845-56. PubMed ID: 8103295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
    Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
    Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.
    Matsushima AY; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1994 Mar; 144(3):573-84. PubMed ID: 8129043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
    Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
    J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
    Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
    Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders.
    Gaidano G; Guerrasio A; Serra A; Carozzi F; Cambrin GR; Petroni D; Saglio G
    Leukemia; 1993 Jul; 7(7):946-53. PubMed ID: 8321046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.